Experience the new reality

Beacon Medical Australia is committed to ensuring we produce the highest quality cannabinoid medicines to meet patients’ needs.

Keep scrolling down to explore what we’re all about

About Us

We're Experienced

Beacon Medical’s parent company is the Canadian-listed VIVO Cannabis who have been growing and selling pharmaceutical-grade medical cannabis to medical patients in a “quality-first” culture since 2014. Our subsidiary Canna Farms was the first producer in British Columbia, Canada to be licensed by Health Canada. Our subsidiary ABcann Medicinals has been producing pharmaceutical-grade medical cannabis in Ontario, Canada since 2016. Our subsidiary Harvest Medicine has seen tens of thousands of medical cannabis patients.

We're Professional

Our state-of-the-art indoor growing facilities are precision controlled environments and some of the most technologically advanced in the world. We manipulate the key plant growth variables for each strain to ensure we consistently produce the highest quality products for patient’s needs.

We know Science Matters

We have taken the art of producing Cannabis and turned it into a science of precision.Our exclusive Cannabis R&D partnership with the University of Guelph ensures that we will continue to remain on the cutting edge of Cannabis cultivation science. Our research agreements with other academic institutions, physicians and pharmaceutical partners ensures that we will remain at the forefront of developing new cannabinoid therapeutics and growing the understanding of how medicinal cannabis can be used to improve patient’s lives.

We're Focused

VIVO provides pharmaceutical grade medicinal cannabis products to medical patients through its subsidiary Beacon Medical and is committed to working with physicians to provide cannabinoid therapeutics to patients. We produce pharmaceutical-grade medicinal cannabis flowers for vaporization, oils for ingestion and continue to develop dosing forms to improve patient outcomes.

Coming Soon

Specialized resources and information

  • Strain Availability and Information
ARE YOU A HEALTH CARE PROFESSIONAL?

Endocannabinoid System

About Medicinal Cannabis

Cannabis has been used by people to treat disease and illness for more than five-thousands years.

Cannabis plants produce many compounds that are active in the body including a family of compounds called the Cannabinoids. These compounds, including ones you may have heard of such as THC and CBD interact with receptors in the body's endocannabinoid system Medical Cannabis imparts its effects through this natural system.

  • THC causes the ‘high’ feeling associated with Cannabis use, but it has also been found to help patients experiencing pain, muscle spasms, nausea, vomiting, and other conditions.
  • CBD can help reduce the ‘high’ caused by THC and has been found to be effective for some patients suffering seizures, inflammation and anxiety.

Cannabinoids such as THC and/or CBD have been used by patients suffering from a range of diseases.

Our medical cannabis plants and the medicines we make from them are produced under strictly controlled conditions. These conditions ensure patients receive a consistent, high quality product, that is free from heavy metals, pesticides and other contaminants which could cause adverse health effects and can be found in illicit cannabis products.

The Endocannabinoid System

The endocannabinoid system is found throughout the body; in the central nervous system, internal organs, connective tissues, glands and immune cells and is responsible for maintaining the body in a state of homeostasis (“relax, eat, sleep, forget, protect”).

The Endocannabinoid System

Despite its pervasiveness (the CB1 receptor is the most abundant G-Protein coupled receptor (GPCR) in the mammalian brain ), the system's discovery has occurred relatively recently; and it is only now that the potential of cannabinoid therapeutics are starting to be fully explored and appreciated.

Endocannabinoid Discovery Timeline

  • CB1 receptor identified

  • Endocannabinoid Anandamide (N-arachidonoylethanolamine) identified

  • CB2 receptor identified

  • Endocannabinoid 2-AG (2-arachidonoylglycerol) identified

Cannabinoid receptors only show low-levels of expression in the primary motor cortex . This combined with their ability to closely interact with the master-regulatory endocannabinoid system may explain why the administration of cannabinoids has been reported as having therapeutic benefits for patients across a range of debilitating diseases.

Our Team

Beacon’s pharmaceutical heritage means that we implicitly understand the need for consistent, pharmaceutical grade Medicinal cannabis products for the administration to patients.

Adam Pirie

Adam Pirie PhD (Pharm. Pharmaceut. Sci.)

Director Operations-Beacon Medical Australia

Over 10 years experience in the leadership and management of complex projects. Experience working in regulatory for large, multi-national pharma; in technology assessment; and early-stage biotech, guiding lead compounds from the pre-clinical to first-in-human phase I.

Track record of building sustainable businesses and executing growth strategy

Barry Fishman

Barry Fishman

Chief Executive Officer

20 years as a business leader, most recently as CEO of European-focused specialty pharmaceutical company Merus Labs. Previously served as CEO of both Teva Canada and Taro Canada.

Michael Bumby

Michael Bumby

Chief Financial Officer

20 years of experience in pharmaceuticals, previously CFO of three publicly held Canadian companies - most recently as CFO of Merus Labs.

Ray Laflamme

Ray Laflamme

SVP, Facilities and Engineering

45 years of engineering, design, construction, project management experience. Commissioned several industrial food grade facilities in North America including the Canna Farms’ facility.

Daniel Laflamme

Daniel Laflamme

President, Canna Farms

Over 15 years of financial, operational and regulatory business experience. Prior to founding CF, was Managing Director for Amberwood Homes.

Andrew LaCroix

Andrew LaCroix

VP, International and General Counsel

Over 20 years of legal experience starting at Stikeman and then his own legal practice.

Joel Mallard

Joel Mallard

Chief Customer Offcer

20 years of sales and marketing experience at Diageo and Cowbell Brewing Co.


Global thought leaders; cannabis research, clinical experience and plant science

Raphael Mechoulam, PhD

The Hebrew University of Jerusalem

The world-renowned cannabis scientist that discovered tetrahydrocannabinol (THC) and cannabidiol (CBD).

Mike Dixon, PhD

University of Guelph

Leading globally recognized plant scientist – specializing in controlled environmental systems.


VIVO is a family of premium brands and businesses, building a world-class cannabis company through the acquisition and development of specialty brands.

Get In Touch

Contact Details

Beacon Medical Australia

Suite 201/697 Burke Road, Camberwell VIC 3124
Email: info@Beaconmedical.com.au
Thank you. The Mailman is on His Way :)
Sorry, don't know what happened. Try later :(